Wannarasmi Ketchart

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 6

Top Topics

Breast Cancer Cells

Estrogen Receptor

Cell Proliferation

Top Venues

Medical oncology (Northwood, London, England)

Clinical and experimental pharmacology & physiology

The Journal of pharmacy and pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Kantasorn Horpratraporn, Patthamapon Adchariyasakulchai, Panot Sainamthip, Wannarasmi Ketchart
Combining lapatinib and palbociclib inhibits cell proliferation and invasion via AKT signaling pathway in endocrine-resistant breast cancer cells. Medical oncology (Northwood, London, England) 41 (2) (2024)
Kantasorn Horpratraporn, Patthamapon Adchariyasakulchai, Panot Sainamthip, Wannarasmi Ketchart
Combining lapatinib and palbociclib inhibits cell proliferation and invasion via AKT signaling pathway in endocrine-resistant breast cancer cells. Medical oncology (Northwood, London, England) 41 (2) (2024)
Kantasorn Horpratraporn, Patthamapon Adchariyasakulchai, Panot Sainamthip, Wannarasmi Ketchart
Combining lapatinib and palbociclib inhibits cell proliferation and invasion via AKT signaling pathway in endocrine-resistant breast cancer cells. Medical oncology (Northwood, London, England) 41 (2) (2024)
Nalinee Pradubyat, Athina Giannoudis, Taha Elmetwali, Panupong Mahalapbutr, Carlo Palmieri, Chalermchai Mitrpant, Wannarasmi Ketchart
1'-Acetoxychavicol Acetate from Alpinia galanga Represses Proliferation and Invasion, and Induces Apoptosis via HER2-signaling in Endocrine-Resistant Breast Cancer Cells. Planta medica (2021)
Piriya Chonsut, Panupong Mahalapbutr, Nalinee Pradubyat, Warinthorn Chavasiri, Piyanuch Wonganan, Wannarasmi Ketchart
Ethoxy mansonone G as an anticancer agent in estrogen receptor-positive and endocrine-resistant breast cancer. The Journal of pharmacy and pharmacology 71 (12) (2019)
Suwisit Manmuan, Nithidol Sakunrangsit, Wannarasmi Ketchart
Salinomycin overcomes acquired tamoxifen resistance through AIB1 and inhibits cancer cell invasion in endocrine resistant breast cancer. Clinical and experimental pharmacology & physiology 44 (10) (2017)